Themis Medicare Financials
NSE: THEMISMED | BSE: 530199
₹120.42
As on 04-Sep-2026 15:59IST
Market cap
₹1,111 Cr
Revenue (TTM)
₹332 Cr
P/E Ratio
27.8
P/B Ratio
2.9
Div. Yield
0.4 %
Income Statement (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
331.61
|
405.51
|
381.76
|
354.32
|
394.61
|
230.67
|
|||||
|
Total Income
|
340.79
|
410.18
|
386.52
|
365.83
|
401.16
|
234.29
|
|||||
|
Total Expenditure
|
373.56
|
356.46
|
330.26
|
286.87
|
298.98
|
181.18
|
|||||
|
EBITDA
|
-41.94
|
49.05
|
51.51
|
67.45
|
95.64
|
49.49
|
|||||
|
Depreciation
|
10.31
|
9.93
|
12.25
|
10.49
|
9.48
|
8.55
|
|||||
|
EBIT
|
-52.25
|
39.12
|
39.26
|
56.96
|
86.16
|
40.95
|
|||||
|
Interest
|
11.20
|
10.04
|
9.38
|
9.56
|
8.77
|
12.71
|
|||||
|
Other Income
|
9.18
|
4.67
|
4.76
|
11.50
|
6.54
|
3.62
|
|||||
|
Exceptional Items
|
92.09
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Profit before Tax
|
37.82
|
39.67
|
53.44
|
72.51
|
95.26
|
41.33
|
|||||
|
Provision for Tax
|
14.62
|
9.84
|
9.92
|
15.61
|
22.38
|
5.63
|
|||||
|
Profit after Tax
|
23.20
|
29.83
|
43.52
|
56.90
|
72.88
|
35.70
|
|||||
|
Minority Interest
|
--
|
0.00
|
0.00
|
0.00
|
0.00
|
0.00
|
|||||
|
Share of Associate
|
16.78
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Consolidated Profit
|
39.97
|
29.83
|
43.52
|
56.90
|
72.88
|
35.70
|
Liabilities (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
398.58
|
402.60
|
377.67
|
339.44
|
287.49
|
218.51
|
|||||
|
Minority Interest
|
--
|
0.00
|
0.00
|
0.00
|
0.00
|
0.00
|
|||||
|
Non-Current Liabilities
|
33.17
|
29.31
|
35.77
|
35.39
|
30.77
|
24.33
|
|||||
|
Current Liabilities
|
166.16
|
165.99
|
162.28
|
149.38
|
123.52
|
128.31
|
|||||
|
Total Liabilities
|
597.91
|
597.90
|
575.72
|
524.21
|
441.78
|
371.14
|
Assets (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
277.82
|
284.17
|
273.25
|
249.43
|
213.62
|
185.67
|
|||||
|
Current Assets
|
304.98
|
313.74
|
302.47
|
274.78
|
228.16
|
185.47
|
|||||
|
Total Assets
|
597.91
|
597.90
|
575.72
|
524.21
|
441.78
|
371.14
|
|||||
|
Total Debt*
|
--
|
82.99
|
95.79
|
91.96
|
78.55
|
85.16
|
|||||
|
Net Current Assets
|
138.82
|
147.74
|
140.19
|
125.40
|
104.64
|
57.16
|
|||||
|
Contingent Liabilities
|
--
|
25.85
|
16.13
|
14.11
|
13.75
|
15.27
|
Cashflow (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
34.71
|
22.09
|
16.09
|
34.39
|
56.98
|
|||||
|
Cash Flow from Investing Activities
|
--
|
-12.17
|
-15.95
|
-23.96
|
-15.59
|
-15.65
|
|||||
|
Cash from Financing Activities
|
--
|
-25.90
|
-8.77
|
0.14
|
-17.55
|
-25.65
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
-3.36
|
-2.62
|
-7.73
|
1.26
|
15.68
|
Financials Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
-2.36
|
3.24
|
4.73
|
6.18
|
7.92
|
3.89
|
|||||
|
Cash EPS (₹)
|
4.34
|
4.32
|
6.06
|
7.32
|
8.95
|
4.82
|
|||||
|
Adjusted Book Value (₹)
|
42.13
|
43.74
|
41.03
|
36.88
|
31.22
|
23.74
|
|||||
|
Dividend per Share (₹)
|
0.41
|
0.50
|
0.50
|
0.50
|
0.50
|
0.43
|
|||||
|
Cash Flow per Share (₹)
|
--
|
3.77
|
2.40
|
17.49
|
37.38
|
62.01
|
|||||
|
Free Cash Flow per Share (₹)
|
--
|
2.09
|
1.79
|
-1.79
|
20.85
|
37.13
|
Profitability Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
10.37
|
13.89
|
20.59
|
31.07
|
18.44
|
|||||
|
ROE (%)
|
-5.59
|
7.65
|
12.14
|
18.16
|
28.84
|
17.82
|
|||||
|
ROA (%)
|
3.91
|
5.08
|
7.91
|
11.78
|
17.93
|
9.97
|
|||||
|
EBIT Margin (%)
|
-15.76
|
9.65
|
10.28
|
16.07
|
21.83
|
17.75
|
|||||
|
Net Margin (%)
|
6.81
|
7.27
|
11.26
|
15.55
|
18.17
|
15.24
|
|||||
|
Cash Profit Margin (%)
|
--
|
9.81
|
14.61
|
19.02
|
20.87
|
19.18
|
Growth Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-12.76
|
6.22
|
7.74
|
-10.21
|
71.07
|
14.43
|
|||||
|
EBIT Growth (%)
|
-18,170.28
|
-0.36
|
-31.07
|
-33.89
|
110.41
|
49.52
|
|||||
|
Net Profit Growth (%)
|
-139.89
|
-31.46
|
-23.51
|
-21.93
|
104.13
|
44.07
|
|||||
|
EPS Growth (%)
|
540.25
|
-31.46
|
-23.52
|
-21.95
|
103.87
|
44.06
|
|||||
|
Book Value Growth (%)
|
--
|
6.60
|
11.28
|
18.15
|
31.68
|
19.51
|
Valuation Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
27.79
|
45.24
|
46.31
|
1.89
|
1.18
|
0.72
|
|||||
|
Price / Book Value
|
2.86
|
3.35
|
5.34
|
3.16
|
2.99
|
1.18
|
|||||
|
Dividend Yield (%)
|
0.41
|
0.34
|
0.23
|
0.43
|
0.54
|
1.53
|
|||||
|
EV/EBITDA
|
-36.68
|
26.43
|
37.19
|
14.52
|
8.91
|
5.99
|
|||||
|
Close Price (₹)
|
109.55
|
146.98
|
218.60
|
117.99
|
93.71
|
28.14
|
|||||
|
High Price (₹)
|
148.00
|
317.00
|
266.00
|
143.53
|
119.88
|
42.40
|
|||||
|
Low Price (₹)
|
64.95
|
141.70
|
109.00
|
68.65
|
27.81
|
22.87
|
|||||
|
Market Cap (₹ Cr)
|
1,110.73
|
1,349.79
|
2,015.66
|
1,073.46
|
858.52
|
257.54
|
Solvency Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.05
|
0.21
|
0.25
|
0.27
|
0.27
|
0.39
|
|||||
|
Short term debt to equity ratio
|
--
|
0.11
|
0.13
|
0.14
|
0.15
|
0.26
|
|||||
|
Current Ratio
|
1.84
|
1.89
|
1.86
|
1.84
|
1.85
|
1.45
|
|||||
|
Quick Ratio
|
1.35
|
1.38
|
1.43
|
1.38
|
1.35
|
0.99
|
|||||
|
Interest Coverage
|
4.38
|
4.95
|
6.70
|
8.58
|
11.86
|
4.25
|
Operating Efficiency Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
53.71
|
43.67
|
46.61
|
40.93
|
25.48
|
33.65
|
|||||
|
Asset Turnover
|
0.56
|
0.69
|
0.69
|
0.73
|
0.97
|
0.64
|
|||||
|
Receivable days
|
--
|
159.79
|
154.39
|
126.49
|
82.40
|
142.49
|
|||||
|
Inventory Days
|
--
|
69.71
|
66.70
|
66.84
|
55.18
|
89.48
|
|||||
|
Payable days
|
--
|
166.51
|
138.08
|
130.58
|
87.30
|
163.89
|
|||||
|
Cash Conversion Cycle
|
--
|
62.99
|
83.02
|
62.75
|
50.27
|
68.08
|